Ronald H. W. Cooper

Executive

CA·SEDI

enGene Therapeutics Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 19 Jun 2026 for enGene Therapeutics Inc., €431k. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Ronald H. W. Cooper: trading record in brief

Ronald H. W. Cooper has a single filing on record, published on 19 June 2026: an option exercise of €431k in enGene Therapeutics Inc. One trade is not enough to describe a pattern. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Ronald H. W. Cooper

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

enGene Therapeutics Inc. (CA)

Declarations1 total

◇

Ronald H. W. Cooper

4 - Director of IssuerExecutives16 Jun 2026enGene Therapeutics Inc.

700,000 CAD19SEDI ↗

400,000 shares@ CA$1.75100.0% of flowOptionsTSXSEDI:4737745

1 of 1 declaration

Ronald H. W. Cooper

Insider track record

Ronald H. W. Cooper: trading record in brief

Companies and markets linked to Ronald H. W. Cooper

Related entities

Ronald H. W. Cooper

Insider track record

Ronald H. W. Cooper: trading record in brief

Companies and markets linked to Ronald H. W. Cooper

Related entities